Short-term Psychodynamic Psychotherapy in Serious Physical Illness

Last updated: March 25, 2025
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Neoplasms

Carcinoma

Cancer Treatment

Treatment

Short-term psychodynamic psychotherapy for patients with serious physical illness (ORPHYS)

Clinical Study ID

NCT05520281
DKH70113404-2
  • Ages > 18
  • All Genders

Study Summary

Life-threatening physical illness may powerfully re-activate existential conflict. There is little evidence to date on the effectiveness of relationship-focused therapies in this patient group.The aim of this study is to pilot a psychodynamic treatment for patients with advanced cancer and high psychological distress.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 18 years and older

  • UICC stage IV solid tumor

  • Informed consent

  • Current physical condition that allows for at least 12 therapy sessions

  • Indication: Presence of a mental disorder with existential stress and limitations incoping capacity

Exclusion

Exclusion Criteria:

  • Acute suicidality

  • Psychotic disorder (ICD-10: F2 diagnosis)

  • Substance dependence or abuse (ICD-10: F1 diagnosis)

  • Structural deficits that interfere with attending to regular appointments

  • Other psychotherapeutic treatment

  • Severe cognitive impairment

  • Severe physical impairment

  • Insufficient German to give informed consent and complete self-report questionnaires

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Short-term psychodynamic psychotherapy for patients with serious physical illness (ORPHYS)
Phase:
Study Start date:
September 15, 2022
Estimated Completion Date:
July 31, 2025

Study Description

Severely physically ill patients may experience existential distress symptoms including helplessness, hopelessness, death anxiety, perceived burdensomeness and a sense of pointlessness. The latter can significantly interfere with end-of-life care processes and outcomes (receipt of treatment according to preferences, expression of desire for hastened death). So far, empirically tested psychotherapeutic programs in advanced life-threatening illness have predominantly been ultra-short and applied supportive and resource-oriented techniques. Psychodynamic treatment allows to address clinically significant existential distress through its conceptualization from early relational life experiences.

The aim of this study is to pilot a psychodynamic treatment for patients with advanced cancer and high psychological distress.The inverstigators will

  1. analyse the feasibility of the treatment, and

  2. investigate changes in process- and patient-relevant outcomes over the course of the treatment

The inverstigators will conduct a single-group pre-post study with five assessment points in which 50 adult patients diagnosed with advanced cancer will receive a manualized psychodynamic short-term therapy. Target parameters are assessed by diagnostic interviews, focus interviews, self-assessment questionnaires as well as electronic patient records. For research objective b) the investigators will compare the intervention group with a matched comparison group of a longitudinal cohort sample (NCT04600206). Matching will be based on stress level, demographic, and medical parameters across the 5 assessment points.

Connect with a study center

  • Clinical Institute for Psychosomatic Medicine and Psychotherapy, University Medical Center Düsseldorf

    Düsseldorf, 40225
    Germany

    Site Not Available

  • University Medical Center Hamburg Eppendorf, Department of Medical Psychology

    Hamburg, 20246
    Germany

    Site Not Available

  • Institute of Social Work, University of Kassel

    Kassel, 34127
    Germany

    Site Not Available

  • Psychosomatics, Psychotherapy and Psychooncology, Medicine II, University of Würzburg

    Würzburg, 97080
    Germany

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.